switch to a different analgesic now that propoxyphene (Darvon-N) is off the market due to safety concerns
January 2011
Many patients will need to switch to a different analgesic now that propoxyphene (Darvon-N) is off the market due to safety concerns.
Many experts say it's about time.
Propoxyphene can increase the risk of arrhythmias...even at usual doses and in patients without cardiac problems.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive